- A study has estimated that MenB vaccination in New Zealand was around 31% effective against gonorrhoea
- This is the first time that a vaccine has been found to prevent cases of gonorrhoea
- Gonorrhoea is becoming more and more difficult to treat as it is becoming resistant to antibiotics
- This merits further investigation, and could have long-term implications for vaccinating teenagers in the UK with the MenB vaccine, potentially improving the cost-effectiveness equation
A new study by researchers in New Zealand has found that teenagers who had been vaccinated with MenB vaccine were significantly less likely to get the sexually transmitted disease gonorrhoea compared to those who were unimmunised. This finding could have wide implications including in the UK which was the first country to routinely introduce the MenB vaccine.